Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Practice Current
  • Practice Buzz

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Clinical Practice
Home
A peer-reviewed clinical neurology journal for the practicing neurologist
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Practice Current
  • Practice Buzz

Share

December 2011; 1 (1) Current Controversies

Multiple sclerosis therapeutic strategies

Use second-line agents as first-line agents when time is of the essence

Mark S. Freedman
First published December 1, 2011, DOI: https://doi.org/10.1212/CPJ.0b013e31823cc2c2
Mark S. Freedman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Multiple sclerosis therapeutic strategies
Use second-line agents as first-line agents when time is of the essence
Mark S. Freedman
Neurol Clin Pract Dec 2011, 1 (1) 66-68; DOI: 10.1212/CPJ.0b013e31823cc2c2

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1502

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 1 no. 1 66-68
DOI: 
https://doi.org/10.1212/CPJ.0b013e31823cc2c2

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published December 1, 2011.

Copyright & Usage: 
Copyright © 2011 by AAN Enterprises, Inc.

Author Disclosures

    1. Mark S. Freedman, MSc, MD, FAAN, FRCPC
  1. Mark S. Freedman, MSc, MD, FAAN, FRCPC
  1. Ottawa Hospital, Ottawa, Canada.
  1. Correspondence to:
    mfreedman{at}ottawahospital.on.ca
View Full Text

Article usage

Article usage: December 2011 to April 2022

AbstractFullPdfSource
Dec 20110431285Highwire
Jan 201209888Highwire
Feb 2012020586Highwire
Mar 201245879Highwire
Apr 2012144939Highwire
May 2012353729Highwire
Jun 2012123234Highwire
Jul 2012112820Highwire
Aug 2012112518Highwire
Sep 2012202928Highwire
Oct 2012233830Highwire
Nov 2012202320Highwire
Dec 2012263225Highwire
Jan 2013212220Highwire
Feb 2013183921Highwire
Mar 2013182924Highwire
Apr 2013242222Highwire
May 2013372011Highwire
Jun 20131457Highwire
Jul 20131232Highwire
Aug 2013756Highwire
Sep 20131323Highwire
Oct 201315313Highwire
Nov 20131449Highwire
Dec 2013736Highwire
Jan 20141035Highwire
Feb 2014524Highwire
Mar 20141034Highwire
Apr 2014655Highwire
May 20141228Highwire
Jun 20141887Highwire
Jul 2014801Highwire
Aug 20141123Highwire
Sep 2014844Highwire
Oct 2014735Highwire
Nov 201413411Highwire
Dec 20141045Highwire
Jan 20151226Highwire
Feb 2015826Highwire
Mar 20151054Highwire
Apr 20152368Highwire
May 2015625Highwire
Jun 2015725Highwire
Jul 2015841Highwire
Aug 20151425Highwire
Sep 2015705Highwire
Oct 20151018Highwire
Nov 20151109Highwire
Dec 20151231Highwire
Jan 2016433Highwire
Feb 2016513Highwire
Mar 2016807Highwire
Apr 2016643Highwire
May 20161147Highwire
Jun 20161139Highwire
Jul 2016676Highwire
Aug 20162738Highwire
Sep 20161156Highwire
Oct 20161434Highwire
Nov 20161014Highwire
Dec 20161523Highwire
Jan 2017910Highwire
Feb 2017922Highwire
Mar 20171538Highwire
Apr 2017925Highwire
May 20171213Highwire
Jun 2017904Highwire
Jul 2017402Highwire
Aug 2017727Highwire
Sep 20171033Highwire
Oct 20171729Highwire
Nov 20172717Highwire
Dec 20174128Highwire
Jan 2018286Highwire
Feb 20182354Highwire
Mar 20181365Highwire
Apr 20182355Highwire
Apr 2018032pmc
May 20182426Highwire
Jun 201804812Highwire
Jun 20183611pmc
Jul 20180505Highwire
Aug 20180391Highwire
Aug 2018034pmc
Sep 20180273Highwire
Oct 20181303Highwire
Nov 20180311Highwire
Dec 20181214Highwire
Jan 20191230Highwire
Feb 20190187Highwire
Mar 201923010Highwire
Apr 201932214Highwire
May 201932112Highwire
Jun 201911211Highwire
Jul 201902615Highwire
Aug 201901614Highwire
Sep 2019233Highwire
Oct 2019286Highwire
Nov 2019186Highwire
Dec 2019379Highwire
Jan 20201175Highwire
Feb 20202195Highwire
Mar 2020183Highwire
Apr 20200101Highwire
May 2020092Highwire
Jun 2020033Highwire
Jul 2020052Highwire
Aug 2020033474Highwire
Sep 20202105Highwire
Oct 2020393Highwire
Nov 2020033Highwire
Dec 20204142Highwire
Jan 20210511Highwire
Feb 2021061Highwire
Mar 20211174Highwire
Apr 2021092Highwire
May 20211153Highwire
Jun 20210144Highwire
Jul 202122012Highwire
Aug 202112312Highwire
Sep 20212187Highwire
Oct 202112424Highwire
Nov 202112716Highwire
Dec 20210142Highwire
Jan 20222152Highwire
Feb 20221186Highwire
Mar 20220103Highwire
Apr 20221255Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • All Clinical Neurology
  • Multiple sclerosis

Alert Me

  • Alert me when eletters are published
Neurology: Clinical Practice: 12 (2)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Clinical Practice |  Print ISSN: 2163-0402
Online ISSN: 2163-0933

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise